Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling-Reference-Cited by-同舟云学术

Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling

Published:2016-02 Issue: Volume:101 Page:54-70
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Osman Islam,Segar Lakshman

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference74 articles.

1. Atherosclerosis—an inflammatory disease;Ross;N. Engl. J. Med.,1999

2. Molecular regulation of vascular smooth muscle cell differentiation in development and disease;Owens;Physiol. Rev.,2004

3. Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy;Yoshimoto;Atherosclerosis,1999

4. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes;Phillips;Circulation,2003

5. Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect;Satoh;Diabetes Care,2003

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota-derived Metabolite, Shikimic Acid, inhibits vascular smooth muscle cell proliferation and migration;Biochemical Pharmacology;2024-11

2. Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action;Biomedicine & Pharmacotherapy;2024-04

3. PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets;Journal of Advanced Research;2024-03

4. Gut Microbiota-Derived Metabolite, Shikimic Acid, Inhibits Vascular Smooth Muscle Proliferation Via the Activation of Ampk Signaling;2024

5. TorS ‐ Reframing a rational for type 2 diabetes treatment;Diabetes/Metabolism Research and Reviews;2023-08-24